Биотерапия опухолевых перикардитов

К. С. Титов, Irina Zh. Shubina, С. М. Волков et al. · Российский биотерапевтический журнал · 2009

23 patients underwent intra-pericardial immunotherapy of metastatic exudative pericarditis at the Institute of Clinical Oncology N.N. Blokhin Russian Cancer Research Center from 1996 to 2006. The immunotherapy involved recombinant interleukin-2 (Ronkoleukin, Biothech, Russia) and autologous LAK-cells generated from lymphocytes of patients' pericardial effusion. Intra-pericardial IL-2/LAK immunotherapy in patients with metastatic exudative pericarditis showed high effectiveness (95,7 %). We suggest that the clinical effects of IL-2/LAK immunotherapy are determined by tumor cell lysis with autologous limphokine activated killers.

Cited by 0 works.

Authors